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A substantial number of human tumors (~10%) are telomerase
negative, and cells in such tumors have been proposed to maintain telomere length by the alternative lengthening of telomeres
(ALT) pathway. Although details of the molecular mechanism
of ALT are largely unknown, previous studies have shown that
telomere homologous recombination (HR) is implicated in the
ALT pathway. MUS81 is a DNA structure-specific recombination endonuclease and functions on aberrant DNA replication
and recombination. Recently, we demonstrate that MUS81 plays
a key role in the maintenance of telomeres in ALT cells (Zeng,
et al. Nature Cell Biology, 2009). The MUS81 endonuclease
specifically localizes to ALT-associated promyelocytic leukemia
nuclear bodies (APBs) and interacts with telomeres in ALT cells.
Depletion of MUS81 leads to reduced telomere recombination
resulting in the growth arrest of ALT cells. The endonuclease
activity of MUS81, regulated by its binding partner TRF2, is
found to be essential for telomere post-replicative recombination. This study provides the first direct evidence that MUS81
specifically functions on ALT recombination-based cell survival.
The specific function of MUS81 on the ALT pathway provides
a potential powerful diagnostic marker and a therapeutic target
for ALT tumors.

Telomere Maintenance and Telomere Recombination
Telomeres are specialized structures at chromosome ends
consisting of tandem repetitive DNA sequences [(TTAGGG)n in
humans] and associated proteins, which are necessary for telomere
function. The structure and function of telomeres are regulated by
a multiprotein complex termed “shelterin,”2,3 which allows cells to
distinguish natural chromosome ends from DNA double-strand
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4511 Forest Park; St. Louis, MO 63108 USA; Tel.: 314.747.5445; Fax:
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breaks and maintains telomere length and stability. Progressive
telomere shortening in normal cells during DNA replication leads
eventually to a permanent halt of cell division referred to as replicative senescence. This end replication problem of human telomeres
has received particular attention due to its implications in ageing
and cancer. Most human tumor cells acquire indefinite replicative capacity to escape from the normal proliferative limitations
through maintaining their telomeres, either by telomerase4 or by
an alternative lengthening of telomeres (ALT) mechanism.5,6
Telomerase-negative cancer cells maintain their telomeres
via the alternative lengthening of telomeres (ALT) pathway.
Although a growing body of evidence demonstrates that the ALT
mechanism is a post-replicative telomere recombination process,
molecular details of this pathway are largely unknown.7-10 In
particular, the highly significant increase in the number of postreplicative telomere exchanges demonstrates that the ALT pathway
is HR-dependent.9,11 The increased telomere recombination is
ALT-specific and extends the proliferative life of ALT cells.12 A
growing body of evidence hints that HR proteins and telomere
associated proteins play a primary role in the ALT pathway.
These proteins co-localize with telomeric (TTAGGG)n repeats
at nuclear substructures known as ALT-associated promyelocytic
leukemia (PML) nuclear bodies (APBs), which are present only
in ALT cells.6,13-15 Imaging of live cells has revealed that an individual telomere may move in and out of contact with an APB,16
suggesting possible on-going telomere extension in ALT cells.
Additionally, APBs are enriched during the G2 phase of the cell
cycle when HR is most active and ALT activity is likely occurring.17-19 APBs preferentially accumulate linear extrachromosomal
telomeric DNA, which may provide DNA substrates for telomere
recombination.20 ALT has only been detected in abnormal situations, such as tumor-derived cell lines or cell lines immortalized in
vitro. It seems likely that ALT occurs due to a dysfunction in the
highly regulated mechanisms controlling telomere recombination.
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MUS81, a highly conserved DNA structure-specific endonuclease, is required for the survival of cells undergoing aberrant
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replication and recombination.21-24
MUS81 functions as an endonuclease by cleaving intact and nicked
Holliday junctions, replication
forks, 3' flap and D-loop substrates
which are preferred for DNA replication and recombination.21,22,24-27
RNA interference experiments
show that MUS81 is required for
mitotic recombination in somatic
human cells.21 MUS81 homozygote and heterozygote knockout
mice have a predisposition to
develop cancer28 and show sensitivity to agents that stall replication
forks, such as hydroxyurea, methyl
methane sulfonate and mitomycin
C.28,29 Because MUS81 functions on aberrant DNA replication
and recombination, it is a candidate “ALT protein”, which might
be required for abnormal telomere
recombination in ALT cells.
In our recent study,1 we have Figure 1. Cell cycle-dependent MUS81 foci formation in ALT cells. U2OS cells (ALT cells) were blocked by
double thymidine treatment and released from 5 hours (S phase) or 13 hours with an additional block by
demonstrated that the MUS81 Hoechst 33342 (G phase). G /G cells were obtained by methionine restriction treatment for 4 days.
1
endonuclease specifically localizes to FACS analysis was 2conducted to0 confirm
cell cycle phases (data not shown). Cells were stained with immuAPBs and associates with telomeric nofluoresence combined with telomeric DNA-FISH. Bright foci staining of FITC-labeled PNA probe (telomeric
DNA in ALT cells, which is enriched C-strand oligo) indicated APBs MUS81 proteins were stained by MUS81 antibody and an Alexa Fluor
during G2 phase of the cell cycle 568-conjugated anti-mouse IgG (Molecular Probes). The merged images showed that MUS81 co-localized
with telomeric DNA in APBs. The percentage of cells with co-localization of MUS81 foci with telomeric DNA
(Fig. 1). Knockdown of MUS81 (PNA probe) is shown. At least 200 cells were scored, and results were summarized from three independent
results in reduction of ALT specific- experiments.
telomere recombination leading to
proliferation arrest of ALT cells.
Furthermore, proliferation of ALT cell requires the endonuclease a post-replicative recombination process, which is essential for
activity of MUS81, and the interaction of MUS81 with TRF2 ALT cell survival. MUS81 does not regulate telomere mainteregulates this enzymatic activity to maintain telomere recombina- nance in non-ALT cells, in agreement with the hypothesis that
tion. Thus, our results indicate that MUS81 is essential for ALT MUS81 only functions on abnormal DNA recombination, such
as in ALT cells with a high frequency of telomere recombination.
cell viability by ensuring efficient telomere recombination.
Our studies also provide clues for studying functions of MUS81
Role of MUS81 in Telomere Recombination
in other biological processes, for example, in DNA damage and
We find that MUS81 contributes to ALT cell survival repair pathways.
We carefully examine telomere length after depletion of MUS81
by promoting telomere recombination.1 In yeast, MUS81 is
by
using Q-FISH and TRF assays and do not observe significant
required for the survival of cells undergoing aberrant replica22,24
telomere
length changes. One possibility is that telomere recomtion and recombination.
However, the biological functions
bination
leads to unequal sister chromatid exchange (SCE) at
of MUS81 in human cells are largely unknown. A variety of
telomeres,
which is responsible for rapid telomere elongation and
models predict the formation and resolution of different DNA
21-24
shortening
events. Before mitosis, telomere recombination leads
structures during homologous recombination.
These structo
exchanges
of equal amounts of telomeric DNA or results in a
tures include 3' flaps, forks, D-loops, nicked, gapped and intact
net
gain
of
telomere
sequences in one chromatid and a net loss in
Holliday junctions. Recent studies have indicated that these
30-32
the
other.
Thus,
the
average changes of telomere length are not
structures are possible in vivo substrates of MUS81.
Our
results show that cleavage of telomere recombination substrates significantly altered. The Q-FISH and TRF assays could only
by MUS81 may be necessary for ALT cells survival, directly detect the overall changes of telomere length and could not address
linking MUS81 endonuclease activity with abnormal telomere on the specific chromosomes. This interpretation is consistent
recombination in ALT cells. In addition, we present evidence with a current model, which indicates maintenance of telomeres
indicating that telomere maintenance in the ALT pathway is by unequal telomere SCE.12 Because telomeres are repetitive
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telomerase-positive cells,34 suggesting that MUS81 is
recruited into APBs in ALT cells. These results support
a model that activation of the ALT pathway is through
recruiting “ALT proteins” to telomeres.14
A recent study reports that the proportion of ALT cells
with APBs is increased following methionine starvation.15
These induced APBs contain TRF1, TRF2, TIN2, RAP1,
the PML protein, the MRN complex, 53BP1, SP100 and
telomeric DNA. We have also observed induction of APBs
containing telomeric DNA upon methionine restriction.
However, MUS81 is not present in these induced APBs
in G0/G1 phase cells (data no shown), indicating that it
might be a specific effect of the methionine starvation on
MUS81 cellular metabolism/localization. These results
also suggest that APBs may have different functions in
different phases of the cell cycle. APBs in G2 phase cells
Figure 2. Proposed model for telomere processing in ALT cells. Telomeres move into may help to conduct telomere recombination. Unlike
APBs for processing recombination in G2 phase of ALT cells. MUS81 is recruited into
other recombination and telomere associated proteins
recombination sites to cleave the recombination structure, which is inhibited by TRF2.
present in APBs, MUS81 to APBs is only enriched in G2
Elongated telomeres move out from APBs into next phase of the cell cycle.
phase cells. This implies that MUS81 specifically functions on the ALT pathway, and not on global telomere
sequences, sister chromatids can find sites of homology anywhere maintenance. These results also implicate that the localization of
to align two telomere strands asymmetrically. Telomere recombina- MUS81 in ALT might be a unique marker for ALT tumors.
tion results in a gain or loss between two telomeres. The daughter
cell inheriting chromosomes with elongated telomeres would Interaction of TRF2 and MUS81 in the ALT Pathway
bypass the limits on proliferative potential. Our data indicate that
TRF2 is thought to be a suppressor for telomere recombiMUS81 enhances telomere recombination to maintain the ALT nation,3,10 although the mechanism by which TRF2 governs
cell proliferation without significant alteration of overall telomere telomere recombination is unclear. We find that TRF2 forms
length, supporting this model.
a complex with MUS81, inhibits the endonuclease activity of
We do not observe obvious chromosome end-to-end fusion MUS81 by suppressing MUS81 binding to the DNA substrates,
in ALT cells after depletion of MUS81 (data not shown). These and mediates T-SCE through interaction with MUS81.1 These
results are consistent with the fact that knockdown of MUS81 do findings, together with the fact that the MUS81 enzymatic
not induce the formation of telomere dysfunctional induced-foci activity is required for telomere recombination and ALT cell
(data not shown), suggesting that MUS81 does not affect telomere viability, support a model that TRF2 suppresses telomere recomend protection in ALT cells. Furthermore, MUS81 depletion do bination through regulation of the endonuclease activity of
not change TRF2 binding on telomeres by the ChIP assay (data MUS81 in the ALT pathway (Fig. 2). We observe that there is
not shown), supporting this conclusion. Although we observe no significant change of telomere circle (t-circle formation) after
increased telomere loss on some chromosome ends in the MUS81- depletion of MUS81 (data not shown), suggesting that t-circles
depleted ALT cells, it is possible that enough telomere sequences may be not involved in MUS81-mediated ALT cell survival.
are still present in these chromosome ends to ensure chromosome However, because a lower level of t-circles may be insufficient to
end protection.
detect, we could not rule out the role MUS81 on t-circle formation. TRF2 mediates t-loop formation and disruption of t-loop
APBs for Telomere Maintenance
by TRF2ΔB mutant generates t-circles.10,35,36 MUS81 does not
APBs are a hallmark of ALT cells and are usually found in <5% interact with TRF2ΔB mutant, implicating that the MUS81
of cells within an asynchronously growing ALT cell population. endonuclease may be involved in the disruption of t-loop, which
Although the function of APBs is not well understood, they have is mediated by TRF2.
been proposed to serve as depots for storage of nuclear factors and
The levels of MUS81 protein in G2 phase cells do not change,1
14,33
provide a platform for telomere maintenance in ALT cells.
suggesting that the recruitment of MUS81 to APBs is subjected
The fact that APBs largely increase in G2 phase of the cell cycle to regulation in ALT cells. TRF2 and MUS81 interaction suggests
and that HR is active in this phase has led to the conclusion that that TRF2 may regulate MUS81 access to APBs, since TRF2
they function on the maintenance of telomeres by recombination. affects APBs formation in G0/G1 cells.15 To test this hypothesis,
We find that MUS81 specifically localizes to APBs and is enriched we examine the localization of MUS81 in APBs after depletion
in G2 phase cells (Fig. 1), supporting the notion that APBs in of TRF2. However, depletion of TRF2 does not change APB
G2 phase are the sites for telomere recombination. MUS81 local- formation and localization of MUS81 to APBs at G2 phase in
izes to nucleoli, but is not present in PML bodies in human ALT cells (data not shown), excluding that TRF2 regulates the
www.landesbioscience.com
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recruitment of MUS81 to APBs. Further investigation will be
needed to clarify which protein is involved in the recruitment of
MUS81 into APBs.

MUS81 for Telomere Maintenance in ALT Cancer Cells
Our observations demonstrate that MUS81 endonuclease is
specifically involved in telomere recombination and in the maintenance of ALT cell survival.1 We propose a model where telomeres
move into APBs for processing recombination based telomere
maintenance after DNA replication during G2 phase of the cell
cycle. MUS81 is recruited into recombination sites to cleave the
recombination structure, for example, D-loop (Fig. 2). TRF2
negatively regulates the MUS81 enzymatic activity to balance this
process. Then, telomeres that completed recombination move out
from APBs into next step of the cell cycle. In this manner, ALT cells
maintain their telomeres and extend the proliferative lifespan.
The telomere maintenance mechanism is essential for the
indefinite proliferation of cancer cells. Understanding the specific
requirements of ALT is key to developing diagnostic tools and
therapies that target this pathway. Inhibiting telomerase activity
in non-ALT tumors may activate the ALT pathway, suggesting
that suppression of ALT activity is important for most tumors.
MUS81, which is specifically present in APBs and is essential for
the ALT cell survival, will provide a powerful diagnostic marker
and a putative therapeutic target for ALT tumors.
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